Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
      • Research Guidelines
        • Minimum Information About Microarray Data Experiments (MIAME)
      • Abstract
      • Acknowledgments
      • Clinical Implications (Only by invitation)
      • Conflict(s) of Interest/Disclosure(s) Statement
      • Figure Legends
      • Figures
      • Novelty and Significance: 1) What Is New, 2) What Is Relevant?
      • References
      • Sources of Funding
      • Tables
      • Text
      • Title Page
      • Online/Data Supplement
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
      • Change of Authorship Form
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Hypertension

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Poster Session I (for Trainees) with Reception

Abstract 235: Chronic Endothelin Type A Receptor Blockade Abolishes Age-dependent Hypertension In Female Intrauterine Growth Restricted Rat Offspring.

Suttira Intapad, Miles A Backstrom, Anthony J Carter, John H Dasinger, Barbara T Alexander
Hypertension. 2014;64:A235
Suttira Intapad
Univ of Mississippi Med center, Jackson, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miles A Backstrom
Univ of Mississippi Med center, Jackson, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony J Carter
Univ of Mississippi Med center, Jackson, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John H Dasinger
Univ of Mississippi Med center, Jackson, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara T Alexander
Univ of Mississippi Med center, Jackson, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics

Jump to

  • Article
  • Info & Metrics
  • eLetters
Loading

Abstract

Birth weight is inversely associated with blood pressure. Placental insufficiency in the rat induces low birth weight indicative of intrauterine growth restriction (IUGR) associated with sex-dependent hypertension in IUGR offspring in young adulthood. However, placental insufficiency programs the development of age-dependent hypertension in the female IUGR rat by 12 months of age. Blood pressure increases with age and the prevalence of hypertension is significantly increased in low birth weight women at 60 relative to 50 years of age. Yet, the exact mechanisms that mediate age-dependent hypertension following a developmental insult are unknown. We previously noted that endothelin mediated via its endothelin type A receptor (ETAR) plays a significant role in blood pressure regulation in hypertensive male IUGR but not in normotensive female IUGR rats in young adulthood. Thus, we hypothesized that endothelin mediated via its ETAR would play a contributory role in the development of age-dependent hypertension in the female IUGR rat. Mean arterial pressure (MAP) was measured via arterial catheter in conscious female control and female IUGR offspring at approximately 12 and 18 months of age in animals that received vehicle or an ETAR antagonist (ABT-627, 5 mg/kg BW, Abbott) in the drinking water for 4 days prior to measure of MAP. MAP was significantly increased in IUGR (135±2 mmHg; P<0.05,) relative to control (121±2 mmHg) at 12 months of age (N=9 per group). MAP was remained significantly elevated in IUGR (149±5 mmHg, P<0.05) relative to control (135±5 mmHg) at 18 months of age (N=5 per group) despite age-dependent increases in MAP in IUGR and control rats. Chronic ETAR blockade significantly decreased MAP in treated IUGR (113±2 mmHg; P<0.05 vs. untreated IUGR, N=6) but blockade of the ETAR had no impact on blood pressure in treated control (134±9 mmHg; N=5) at 18 months of age. Thus, these findings indicate that age augments the importance of endothelin via its ETAR in the etiology of hypertension programmed by IUGR but does not contribute to the age-dependent increase in blood pressure in the female control. Furthermore, this study highlights the need for sex- and age-specific considerations in the management of hypertension following a developmental insult.

  • Endothelin
  • Womens
  • Aging
  • Author Disclosures: S. Intapad: B. Research Grant (includes principal investigator, collaborator, or consultant and pending grants as well as grants already received); Significant; AHA 12POST11980021, P20GM104357. M.A. Backstrom: None. A.J. Carter: None. J.H. Dasinger: None. B.T. Alexander: B. Research Grant (includes principal investigator, collaborator, or consultant and pending grants as well as grants already received); Significant; R01 HL074927, P01-HL51971, GM104357.

  • This research has received full or partial funding support from the American Heart Association, Greater Southeast Affiliate (Alabama, Florida, Georgia, Louisiana, Mississippi, Puerto Rico & Tennessee).

  • © 2014 by American Heart Association, Inc.
Back to top
Previous Article

This Issue

Hypertension
September 2014, Volume 64, Issue Suppl 1
  • Table of Contents
Previous Article

Jump to

  • Article
  • Info & Metrics

Article Tools

  • Citation Tools
    Abstract 235: Chronic Endothelin Type A Receptor Blockade Abolishes Age-dependent Hypertension In Female Intrauterine Growth Restricted Rat Offspring.
    Suttira Intapad, Miles A Backstrom, Anthony J Carter, John H Dasinger and Barbara T Alexander
    Hypertension. 2014;64:A235, originally published February 5, 2015

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Hypertension.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Abstract 235: Chronic Endothelin Type A Receptor Blockade Abolishes Age-dependent Hypertension In Female Intrauterine Growth Restricted Rat Offspring.
    (Your Name) has sent you a message from Hypertension
    (Your Name) thought you would like to see the Hypertension web site.
  • Share on Social Media
    Abstract 235: Chronic Endothelin Type A Receptor Blockade Abolishes Age-dependent Hypertension In Female Intrauterine Growth Restricted Rat Offspring.
    Suttira Intapad, Miles A Backstrom, Anthony J Carter, John H Dasinger and Barbara T Alexander
    Hypertension. 2014;64:A235, originally published February 5, 2015
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Hypertension

  • About Hypertension
  • Instructions for Authors
  • AHA CME
  • Guidelines and Statements
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
7272 Greenville Ave.
Dallas, TX 75231
email: hypertension@heart.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured